Depomed, Inc. (Nasdaq: DEPO) issued the following statement in response to the Schedule 13D filed April 7 with the Securities ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

13Ds Corporate News Management Changes

Mizuho Securities Raises Price Target on Depomed (DEPO) Following Starboard's Activism Announcement; Reiterates Neutral April 11, 2016 7:28 AM Depomed Issues Statement in Response to Starboard Value LP 13D FilingApril 8, 2016 9:06 AM Starboard Delivers Letter to Depomed CEO and Board of DirectorsApril 8, 2016 8:01 AM Depomed (DEPO) Attracts Activists - Mizuho April 8, 2016 6:54 AM Starboard Value LP Shows New 9.8% Stake in DepoMed, Inc. (DEPO); Seeks to Replace DirectorsApril 7, 2016 5:41 PM Starboard Value files 13D on Depomed (DEPO)April 7, 2016 5:34 PM Form SC 13D DEPOMED INC Filed by: Starboard Value LPApril 7, 2016 5:29 PM